Having trouble viewing this e-mail? Click here

ModernMedicine/Physician's Focus
Screening for Prostate Specific Antigen

Prostate-specific antigen (PSA) is the serum biomarker most widely used to screen for prostate cancer and monitor patients with disease. Efforts to standardize PSA assays were undertaken a decade ago, but PSA standardization remains controversial. ModernMedicine presents information to help you decide how to best proceed with PSA screening.

Covered in the Physician�s Focus:

  • Merits of PSA screening affirmed in AUA Best Practice Statement
  • Using PSA more intelligently may reduce prostate cancer deaths
  • Prostate specific antigen standardization: Making sense of the controversy
  • Is reimbursement for repeat PSA testing possible?
  • PATIENT HANDOUT: PSA

Click here to access these resources…

You are subscribed to ModernMedicine.com. To unsubscribe, click here

To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.